Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Among statin-treated patients, LDL, non-HDL and apoB cholesterol biomarkers were associated with increased risks of cardiovascular events.

Sniderman AD, Thanassoulis G.

Evid Based Med. 2013 Apr;18(2):73-4. doi: 10.1136/eb-2012-100787. Epub 2012 Aug 14. No abstract available.

PMID:
22893654
[PubMed - indexed for MEDLINE]
2.

Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis.

Boekholdt SM, Arsenault BJ, Mora S, Pedersen TR, LaRosa JC, Nestel PJ, Simes RJ, Durrington P, Hitman GA, Welch KM, DeMicco DA, Zwinderman AH, Clearfield MB, Downs JR, Tonkin AM, Colhoun HM, Gotto AM Jr, Ridker PM, Kastelein JJ.

JAMA. 2012 Mar 28;307(12):1302-9. doi: 10.1001/jama.2012.366. Erratum in: JAMA. 2012 Apr 25;307(16):1694. JAMA. 2012 May 9;307(18):1915.

PMID:
22453571
[PubMed - indexed for MEDLINE]
3.

Lipid parameters and cardiovascular events in patients taking statins.

Brook RD, Rubenfire M.

JAMA. 2012 Jul 11;308(2):132; author reply 132-3. doi: 10.1001/jama.2012.6616. No abstract available.

PMID:
22782403
[PubMed - indexed for MEDLINE]
4.

Lipid parameters and cardiovascular events in patients taking statins.

Martin SS, Jones SR.

JAMA. 2012 Jul 11;308(2):131-2; author reply 132-3. doi: 10.1001/jama.2012.6614. No abstract available.

PMID:
22782402
[PubMed - indexed for MEDLINE]
5.

Achievement of recommended lipid and lipoprotein levels with combined ezetimibe/statin therapy versus statin alone in patients with and without diabetes.

Guyton JR, Betteridge DJ, Farnier M, Leiter LA, Lin J, Shah A, Johnson-Levonas AO, Brudi P.

Diab Vasc Dis Res. 2011 Apr;8(2):160-72. doi: 10.1177/1479164111406457.

PMID:
21562068
[PubMed - indexed for MEDLINE]
Free Article
6.

Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials.

Robinson JG, Wang S, Jacobson TA.

Am J Cardiol. 2012 Nov 15;110(10):1468-76. doi: 10.1016/j.amjcard.2012.07.007. Epub 2012 Aug 17. Review.

PMID:
22906895
[PubMed - indexed for MEDLINE]
7.

Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.

Sniderman AD, Furberg CD, Keech A, Roeters van Lennep JE, Frohlich J, Jungner I, Walldius G.

Lancet. 2003 Mar 1;361(9359):777-80. No abstract available.

PMID:
12620753
[PubMed - indexed for MEDLINE]
8.

Zetia (ezetimibe).

Kloner RA.

Congest Heart Fail. 2003 Mar-Apr;9(2):109-10. No abstract available.

PMID:
12671344
[PubMed - indexed for MEDLINE]
9.

HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.

Barter P, Gotto AM, LaRosa JC, Maroni J, Szarek M, Grundy SM, Kastelein JJ, Bittner V, Fruchart JC; Treating to New Targets Investigators.

N Engl J Med. 2007 Sep 27;357(13):1301-10.

PMID:
17898099
[PubMed - indexed for MEDLINE]
Free Article
10.

ApoB/A1 and LDL-C/HDL-C and the prediction of cardiovascular risk in statin-treated patients.

Liem AH, van de Woestijne AP, Roeters van Lennep HW, Zwinderman AH, van der Steeg WA, Jukema JW.

Curr Med Res Opin. 2008 Feb;24(2):359-64.

PMID:
18081989
[PubMed - indexed for MEDLINE]
11.

Alteration of relation of atherogenic lipoprotein cholesterol to apolipoprotein B by intensive statin therapy in patients with acute coronary syndrome (from the Limiting UNdertreatment of lipids in ACS With Rosuvastatin [LUNAR] Trial).

Ballantyne CM, Pitt B, Loscalzo J, Cain VA, Raichlen JS.

Am J Cardiol. 2013 Feb 15;111(4):506-9. doi: 10.1016/j.amjcard.2012.10.037. Epub 2012 Dec 10.

PMID:
23237107
[PubMed - indexed for MEDLINE]
12.

Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.

Querton L, Buysschaert M, Hermans MP.

J Clin Lipidol. 2012 Sep-Oct;6(5):434-42. doi: 10.1016/j.jacl.2012.04.002. Epub 2012 Apr 12.

PMID:
23009779
[PubMed - indexed for MEDLINE]
13.

Hydroxypropylmethylcellulose lowers cholesterol in statin-treated men and women with primary hypercholesterolemia.

Maki KC, Carson ML, Miller MP, Anderson WH, Turowski M, Reeves MS, Kaden V, Dicklin MR.

Eur J Clin Nutr. 2009 Aug;63(8):1001-7. doi: 10.1038/ejcn.2009.9. Epub 2009 Feb 11.

PMID:
19209184
[PubMed - indexed for MEDLINE]
14.

Stricter cholesterol guidelines broaden indications for the 'statin' drugs.

Capriotti T.

Medsurg Nurs. 2003 Feb;12(1):51-7. Review. No abstract available.

PMID:
12619600
[PubMed - indexed for MEDLINE]
15.

Efficacy and safety of treatment with low-dose fluvastatin in hypercholesterolemic renal transplant recipients.

Akiyama T, Ishii T, Imanishi M, Nishioka T, Matsuura T, Kurita T.

Transplant Proc. 2001 May;33(3):2115-8. No abstract available.

PMID:
11377469
[PubMed - indexed for MEDLINE]
16.

Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels.

Ballantyne CM, Andrews TC, Hsia JA, Kramer JH, Shear C; ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study.

Am J Cardiol. 2001 Aug 1;88(3):265-9.

PMID:
11472705
[PubMed - indexed for MEDLINE]
17.

Effects of ezetimibe, simvastatin and ezetimibe/simvastatin on correlations between apolipoprotein B, LDL cholesterol and non-HDL cholesterol in patients with primary hypercholesterolemia.

Farnier M, Guyton JR, Jensen E, Polis AB, Johnson-Levonas AO, Brudi P.

Atherosclerosis. 2013 Aug;229(2):415-22. doi: 10.1016/j.atherosclerosis.2013.05.010. Epub 2013 Jun 5.

PMID:
23880197
[PubMed - indexed for MEDLINE]
18.

Effects of fluvastatin on lipid profile and apolipoproteins in Chinese patients with hypercholesterolemia.

Tomlinson B, Mak TW, Tsui JY, Woo J, Shek CC, Critchley JA, Masarei JR.

Am J Cardiol. 1995 Jul 13;76(2):136A-139A.

PMID:
7604789
[PubMed - indexed for MEDLINE]
19.

Effect of fluvastatin on intermediate density lipoprotein (remnants) and other lipoprotein levels in hypercholesterolemia.

Broyles FE, Walden CE, Hunninghake DB, Hill-Williams D, Knopp RH.

Am J Cardiol. 1995 Jul 13;76(2):129A-135A.

PMID:
7604788
[PubMed - indexed for MEDLINE]
20.

Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.

Evans M, Roberts A, Davies S, Rees A.

Drugs. 2004;64(11):1181-96. Review.

PMID:
15161326
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk